
Practice Guidelines for Group Psychotherapy
Concurrent Therapies
Although the effectiveness of
group psychotherapy as an independent therapeutic modality has been well
demonstrated (Burlingame, et al., 2004), group therapy clients also may commonly
participate in a concurrent form of treatment: individual therapy,
pharmacotherapy, or a 12-step group. Group therapists aim at proper integration
of these forms of therapy, recognizing opportunities for therapy synergy,
complementarity, facilitation and sequencing (Paykel, 1995; Nevonen & Broberg,
2006). Clarity about the principles of integration of modalities is useful in
ensuring maximum benefit. Therapy integration increases the scope of clients
that can be treated in group therapy and respects client choice and autonomy
(Feldman & Feldman, 2005). Combining treatments however carries potential risks
and may be contraindicated if the second modality is redundant and unnecessary,
or incompatible with the initial therapy, as will be described (Rosser, et al.,
2004). Concurrent individual therapy may dilute the group therapy intensity by
reducing the press group members may have to address important material.
Engagement within the group may also be diminished if many group members are
participants in an individual therapy (Davies, et al., 2006).
Concurrent Group and
Individual Therapy. Group and individual therapy are generally of equal
effectiveness (McRoberts, et al., 1998) but achieve their results through
different mechanisms and therapist intent (Kivlighan & Kivlighan 2004; Holmes &
Kivlighan, 2000). Group psychotherapy tends to emphasize the interpersonal and
interactional: individual therapy tends to emphasize the intrapsychic. They may
be effectively co-administered. Conjoint therapy refers to situations in which
the group and individual therapist are different: in combined therapy one
therapist provides both treatments (Porter, 1993) Conjoint therapy may increase
the therapeutic power of treatment by adding the power of multiple therapeutic
settings; maturational opportunities; transference objects; observers and
interpreters, generally adding group therapy atop an established individual
therapy (Ormont, 1981). Clarity about the reason for adding a second therapy
and agreement about the objectives of treatment between the referring therapist,
group therapist and client increases the likelihood of successful treatment.
Group therapy may be added to individual therapy to move into the interpersonal
and multi-personal from the dyadic and intrapsychic; facilitate interpersonal
skill acquisition; or activate the psychotherapy. Individual therapy added to
group therapy may help maintain a patient in group therapy who might otherwise
terminate the group prematurely, or address psychological issues the group
unlocks for the client that require more focused attention (Yalom & Leszcz,
2005). Simply adding a second therapy is unlikely to remedy a resistance to the
first therapy and may encourage avoidance of working through.
Conjoint therapy works best
when the client provides informed consent for ad lib communication between the
group and individual therapist; recognizes the importance of working in good
faith in both modalities; and accepts the responsibility of bringing clinical
material appropriately to each setting. A mutual, respectful collaboration
between the individual and group therapist reduces the potential for
competitiveness, rivalry, countertransference or client splitting and
projections of idealization and devaluation to undermine one modality or the
other (Ulman, 2002; Gans, 1990). Mutual respect and open dialogue between both
therapists, although time-consuming, increases therapy effectiveness. Failure to
communicate between therapists may well undermine both psychotherapies.
In combined group and
individual therapy one therapist provides both forms of therapy and hence may
have fuller and more immediate access to client information than in conjoint
therapy. The group should be homogeneous for this dimension to reduce the
potential of stimulating envy and generating unequal status of clients in group
therapy. Frequency of meetings in conjoint and combined therapy can be
determined mutually and may occur once-weekly for both or weekly only for group
therapy with the individual therapy occurring at various frequencies. Ending of
therapy can be done simultaneously or sequentially, mindful however that each
therapy’s ending is fully addressed.
Dealing with client
information at the interface of modalities may pose a therapeutic challenge that
can be best addressed by underscoring the client’s responsibility for bridging
between settings. The therapist should operate with maximum discretion and
judgment but can offer no guarantee of absolute confidentiality across
modalities (Lipsius, 1991; Leszcz, 1998). Difficulties in addressing
relevant material in one setting or the other is best viewed as an opportunity
to understand core difficulties within the client and the feeling of impasse may
become an important therapeutic opportunity. Therapists are encouraged to
preserve the essence of each treatment modality and explore in detail interface
points between the modalities with a view to deepening the work in each.
The therapist may encourage the client to address material in the appropriate
setting and may ultimately introduce it if therapist efforts to support and
facilitate the client addressing the interface through encouragement and
gradually increasing the degree of inference in interventions fail. Working
through the resistance is generally of greater therapeutic value than merely
achieving the self-disclosure.
Combining Group Therapy
and Pharmacotherapy. The majority of group therapists will have clients in
their groups who will require pharmacotherapy, often for treatment of chronic
depression, chronic dysthymia and co-morbid personality and depressive
difficulties (Stone, et al., 1991). Often untreated depression is a cause of
impasse in psychotherapy and the appropriate use of antidepressant medication
may increase the client’s access to psychotherapy, creating a level playing
field for psychological treatment to ensue (Salvendy & Joffe, 1991).
Alternately, group therapy in a post-acute phase of treatment may provide
interpersonal and cognitive skills that will improve patient resilience and
diminish vulnerability to subsequent relapse (Segal, et al., 2001).
If the group therapist is the
prescriber of medication, logistical difficulties may arise regarding proper
monitoring of the antidepressant medication within the group setting alone (Rodenhauser
& Stone, 1993). For this reason a separate meeting is indicated for monitoring
of medication. Alternately a colleague may be engaged to prescribe and monitor
medications (Salvendy & Joffe, 1991).
In situations in which two
treaters are involved, clarity about communication, responsibility for the
client and accessibility of the client to the prescriber increases the
likelihood of an effective treatment (Segal, et al., 2001). Each treater
should inform the other fully and operate with a sense of mutual respect and
full valuing of both the psychological and biological dimensions of care.
Interprofessional practice is predicated upon this kind of mutuality and
collaboration (Oandasan, et al., 2003). Clarity about the objectives of
pharmacotherapy is useful, recognizing that in some instances pharmacotherapy
adds little to an already effective psychotherapy (Rosser & Simpson, 2004).
In instances in which
medication is clearly indicated, the group therapist should anticipate the
psychological meaning and impact of medication on the client’s sense of personal
self-control and attribution of responsibility, emotional availability, and
connection in the group, as well as impact on the logistics of treatment (Rodenhauser,
1989; Porter, 1993; Gabbard, 1990). The prescription of medications may well
have multiple meanings that impact the client receiving medication, other
clients in the group and the group as a whole, ranging from encouragement and
recognition of the therapist’s commitment to client care, to feelings of
personal shame and stigmatization to discouragement that psychotherapy has been
insufficient. In the same way that the group and individual therapists are most
effective when they demonstrate mutual respect and valuing, the same is true for
the pharmacotherapist and group therapist. Dogmatic overvaluing of one modality
and devaluation of the other will create a strain on the client and undermine
the synergistic benefits combined treatment may create.
Twelve-Step Groups.
The broad reach of 12-step groups and their recognized effectiveness in
facilitating abstinence from addictions predict the likelihood that clients that
have been in 12-step groups or are currently in 12-step groups will also be in
leader-led group psychotherapy (Ouimette, et al., 1998; Lash, et al., 2001;
Khantzian, 2001). In this instance, as there is no other treater, it
becomes the responsibility of the group therapist to facilitate the
collaboration between the two models of treatment, building atop the 12-step
treatment, by addressing the psychological and interpersonal context of
addiction in a complementary fashion.
Two important issues
distinguish 12-step groups from group psychotherapy: First, feedback or core
cross-talk is virtually absent in 12-step groups in contrast with their high
value in group psychotherapy. Second, attitudes toward extra-group contact are
very different in 12-step groups. Extra-group contact between members and the
sponsor/sponsee relationship are of critical importance in contrast to the less
permeable boundary issues around extra-group contact in group therapy.
Recognizing these differences, the group therapist can better prepare a client
transitioning into a psychotherapy group from a 12-step group environment,
anticipating potential sources of antipathy, confusion or apprehension about the
different ways in which these two group formats work. The maintenance of
sobriety is a key objective in the treatment of clients with addictions, and the
group leader may need to pace the process of exploration so that it is
containable by the client, cognizant of client vulnerabilities to relapse.
Group psychotherapy and
12-step groups may employ different “narratives of recovery” (Weegman, 2004) but
the historical antipathy between mental health treatment and addiction treatment
is slowly being replaced by an increasing awareness and respect for the
effectiveness of both and for their compatibility. The group therapist will be
most effective if he/she has an appreciation for the 12-step program and how
these steps and culture can be integrated into interpersonal and dynamic forms
of group psychotherapy. The group therapist’s familiarity with the language
employed in 12-step groups will also facilitate this process. Group therapy
complements the 12-step articulation of the importance of self-repair through
relationships; self-reflection; self-disclosure; and personal accountability in
the context of trusting relationships (Matano & Yalom, 1991; Flores, 2004;
Freimuth, 2000; Yalom & Leszcz, 2005).
Summary
1. Group therapy is
effective as an independent treatment format for many individuals, particularly
when the issues are framed in interactional and interpersonal terms.
2. Individuals may be
in group therapy in conjunction with individual therapy, pharmacotherapy or
other therapeutic formats such as a 12 step program.
3 Conjoint therapy
in which different therapists provide individual and group therapy requires a
trusting and open relationship between the therapists which has the sanction of
the client.
4. In combined
therapy, the same therapist provides individual and group therapy to the same
set of individuals. It is important for the therapist in this format to keep
the treatment formats distinct and to respect the privacy and autonomy of the
individuals, allowing them to bring up material at their own pace. It may at
times be therapeutically useful to help the individuals address material in
group.
5. Whether conjoint
or combined, it is essential that both therapies work within their own framework
- group in an interpersonal mode and individual on intrapsychic or behavioral
issues.
6.
Pharmacotherapy and group therapy can be effectively combined.
7. When the therapist
is the prescriber, it is helpful to have a separate time to attend to the
technical issues related to medication, always recognizing that medication usage
has its own dynamic and interpersonal aspects which may also be addressed in the
group therapy. When the treaters are different, it is essential that mutual
respect and professional collaboration be fostered in order for the benefits of
the two treatments to be maximized.
8. In all multiple
treatments, the therapists and clients are best served when mutuality and
collaboration are the guiding principles.
Return to Table of Contents
©2007 American
Group Psychotherapy Association
|